The Food and Drug Administration (FDA) has approved eight novel coronavirus disease 2019 (Covid-19) test kit products for commercial use.
Two of the approved kits are from Korea and two are from China.
The FDA has not yet approved any point-of-care or rapid test kits for COVID-19.
These approved kits are PCR-based reagent kits intended for use by hospitals or laboratories with testing capacity, not for point-of-care or home use.
The four products have complied with the FDA's requirements under Memorandum No. 2020-006.
The Department of Health (DOH) has sent equipment to sub-national labs in Davao, Cebu, and Baguio for testing.
The country's testing capacity is currently limited due to a shortage of test kits, though more are expected to arrive soon to boost capabilities.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.




